缩宫素在剖宫产手术中剔除子宫肌瘤效果分析

Analysis of the Effect and Safety of Oxytocin in Removing Uterine Fibroids During Cesarean Section

目的:探讨剖宫产术中剔除子宫肌瘤时应用缩宫素的效果。方法:选取2019年3月—2020年9月期间该院112例妊娠期伴子宫肌瘤患者作为研究对象,采用随机编号法将其分为两组,对照组单纯分娩后再行子宫肌瘤切除术,观察组剖宫产术中行子宫肌瘤切除术,观察两组患者手术指标、并发症发生率及新生儿健康情况。结果:两组患者手术时间、住院时间、术中出血量、术后出血量及缩宫素使用量差异无统计学意义(P>0.05);观察组患者并发症发生率明显低于对照组(3.57%<23.21%),差异有统计学意义(P<0.05);两组新生儿体质量和5 min阿氏评分(Apgar)差异无统计学意义(P>0.05)。结论:观察组妊娠期伴子宫肌瘤患者剖宫产术中实施子宫肌瘤剔除,并未增加缩宫素使用量,对手术时间、术后出血风险及新生儿5 min Apgar评分无影响,还能有效减少患者并发症风险,安全性高。

Objective: To explore the effect of applying oxytocin when removing uterine fibroids during cesarean section. Methods: From March 2019 to September 2020, 112 patients with uterine fibroids in pregnancy were selected as the research subjects. They were divided into two groups by random numbering method. The control group received uterine fibroids after delivery. In the observation group, uterine myomectomy was performed during cesarean section. The surgical indicators, the incidence of complications and the health of the newborns were observed in the two groups. Results: There was no significant difference in operation time, hospitalization time, intraoperative blood loss, postoperative blood loss and oxytocin usage between the two groups of patients(P > 0.05);the incidence of complications in the observation group was significantly lower than that in the control group(3.57%<23.21%), and the difference was statistically significant(P<0.05);there was no significant difference in the weight and 5-min Apgar score(Apgar) between the two groups of newborns(P > 0.05). Conclusion: Carrying out uterine fibroids during cesarean section in the observation pregnant women with uterine fibroids did not increase the amount of oxytocin, and had no effect on the operation time, postoperative bleeding risk, and 5 min Apgar scores of newborns, and it could effectively reduce the high risk of patient complications, with high safety.